A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
<h4>Background</h4>Viral myocarditis, which is most prevalently caused by Coxsackievirus B3 (CVB3) infection, is a serious clinical condition characterized by cardiac inflammation. However, efficient therapies targeting inflammation are still lacking and much needed. A20, also known as t...
Main Authors: | Jun Gui, Yan Yue, Ruizhen Chen, Wei Xu, Sidong Xiong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23029542/?tool=EBI |
Similar Items
-
An Albumin-Binding Domain Peptide Confers Enhanced Immunoprotection Against Viral Myocarditis by CVB3 VP1 Vaccine
by: Yue Gao, et al.
Published: (2021-09-01) -
Dpep2 Emerging as a Modulator of Macrophage Inflammation Confers Protection Against CVB3-Induced Viral Myocarditis
by: Xiaoli Yang, et al.
Published: (2019-03-01) -
Direct gene transfer with IP-10 mutant ameliorates mouse CVB3-induced myocarditis by blunting Th1 immune responses.
by: Yan Yue, et al.
Published: (2011-01-01) -
Protective Function of STAT3 in CVB3-Induced Myocarditis
by: Diana Lindner, et al.
Published: (2012-01-01) -
STAT3 Suppresses Cardiomyocytes Apoptosis in CVB3-Induced Myocarditis Via Survivin
by: Qiaoyu Wang, et al.
Published: (2021-01-01)